508.460.8822 Contact Us

Focused on Customer Success

We believe that developing effective spray and aerosol delivered therapies requires in-depth knowledge and expertise to understand and control the complex relationships between drug delivery devices, formulations, and human usage that drive product performance.  Our sole focus is to deliver on the idea that applying intelligent automation technology, modern data analysis, and proven experimentation techniques leads directly to superior product knowledge and to successful therapies reaching those that need them far sooner than possible any other way.  Branded and generic pharmaceutical companies, device manufacturers, CDO/CRO/CMO’s, and regulatory agencies around the world believe in this focus and work with us to constantly elevate the standards in the industry and deliver great therapies – why don’t you?

Read More
 
"Proveris Scientific Corporation provides expert support for nasal developers. They are fast, reliable and are professionals at installing of their equipment and supports in demanding challenges." Dr. Peter Svete, Head of Physical Analytics, Lek Pharmaceuticals d.d.
 
 
"Proveris provides insightful and thorough test services. We would recommend working with Proveris. Proveris has great expertise in spray analysis." Elaine Schutte, Chief Development Officer, ProFibrix
 
 
"I want to express my sincere gratitude towards Proveris and the service team for being there to make sure our study goes well. The study just completed few minutes ago and thankfully everything went well.......while we conducted SAC study. It was a great display of professionalism by Proveris." ,
 
 
"As customary, Proveris's service team provided excellent service and was able to answer my questions." ,
 
 
"Thank you for the thorough training on our new equipment. I wish more companies would implement your hands on approach when it comes to training. Thanks again." ,
 
 
"Together with Proveris's instruments and software, the complete solution provides the scalability Aptar Pharma needs to perform robust, high through-put product testing." Salim Haffar, President, Aptar Pharma